Salem M A, Wolff G L
Lutcher Brown Department of Biochemistry, Whittier Institute for Diabetes and Endocrinology, Scripps Memorial Hospital, La Jolla, California 92037.
Proc Soc Exp Biol Med. 1989 Jun;191(2):113-23. doi: 10.3181/00379727-191-42896.
Insulin-like and anti-insulin effects of human growth hormone (hGH) were examined by determining the effects of two peptides representing portions of the hGH molecule in lean agouti A/a and obese yellow Avy/A and ob/ob mice. The peptides were the amino terminal segment, residue 1-43 (hGH1-43), which has been shown to potentiate the response to insulin and another peptide, hyperglycemic peptide (HP), with unknown structure, which has anti-insulin activity. The anti-insulin component is an acidic low molecular weight peptide which co-purifies with hGH but was not recognized by antibodies to intact hGH and did not cross-react with anti-hGH1-43 antiserum. The purpose of these studies was to further understand the multiple actions of hGH and its acute and chronic effects on response to insulin. Injections of hGH1-43 dramatically enhanced the effect of insulin on glucose clearance of obese yellow Avy/A and ob/ob mice and increased the insulin-stimulated glucose oxidation in adipose tissue of yellow mice, but had no direct effect on blood glucose or insulin levels of either genotype. Administration of HP to obese yellow mice produced hyperglycemia and suppressed serum insulin concentrations. Tissues from lean agouti and obese yellow mice treated with HP in vitro showed decreased basal and insulin-stimulated glucose oxidation as well as decreased 14C incorporation into lipids. Chronic treatment of obese yellow and ob/ob mice with HP increased fasting blood glucose and impaired glucose tolerance. The effect of HP was more pronounced in obese yellow mice and the ob/ob mice were more sensitive to the diabetogenic actions of intact hGH. These data provide further evidence for the existence of two opposing biologic activities derived from disparate amino acid sequences in hGH. Additionally, the data indicate that assays using obese yellow Avy/A mice can distinguish the effects of hGH from those of the individual peptides to a greater degree than assays using obese ob/ob mice.
通过测定代表人生长激素(hGH)分子部分片段的两种肽对瘦型刺豚鼠A/a以及肥胖黄色Avy/A和ob/ob小鼠的作用,研究了hGH的胰岛素样和抗胰岛素作用。这两种肽分别是氨基末端片段,即第1至43位残基(hGH1-43),已证明其能增强对胰岛素的反应;另一种是结构未知的高血糖肽(HP),具有抗胰岛素活性。抗胰岛素成分是一种酸性低分子量肽,它与hGH共纯化,但不被完整hGH的抗体识别,也不与抗hGH1-43抗血清发生交叉反应。这些研究的目的是进一步了解hGH的多种作用及其对胰岛素反应的急性和慢性影响。注射hGH1-43可显著增强胰岛素对肥胖黄色Avy/A和ob/ob小鼠葡萄糖清除的作用,并增加黄色小鼠脂肪组织中胰岛素刺激的葡萄糖氧化,但对两种基因型小鼠的血糖或胰岛素水平无直接影响。给肥胖黄色小鼠注射HP会导致高血糖并抑制血清胰岛素浓度。体外经HP处理的瘦型刺豚鼠和肥胖黄色小鼠的组织显示基础和胰岛素刺激的葡萄糖氧化降低,以及14C掺入脂质减少。用HP对肥胖黄色和ob/ob小鼠进行慢性治疗会增加空腹血糖并损害葡萄糖耐量。HP的作用在肥胖黄色小鼠中更明显,而ob/ob小鼠对完整hGH的致糖尿病作用更敏感。这些数据为hGH中不同氨基酸序列产生的两种相反生物活性的存在提供了进一步证据。此外,数据表明,与使用肥胖ob/ob小鼠的实验相比,使用肥胖黄色Avy/A小鼠的实验能在更大程度上区分hGH和单个肽的作用。